Formulations with controlled release of active ingredient

Details Formulations with controlled release of active ingredient Formulations with controlled release of active ingredient

A - Human Necessities

61

K

A61K 31/522 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 47/38 (2006.01) A61P 15/00 (2006.01)

Patent

CA 2566278

The invention relates to novel controlled-release galenic dosage forms that contain the PDE 5 inhibitor vardenafil and/or pharmaceutically acceptable salts, hydrates, solvates and/or polymorphous forms thereof as the active ingredient, and to the production thereof. The invention also relates to the use of these novel galenic dosage forms as drugs and to their use in the production of drugs for use in the treatment and/or prevention of human and animal diseases.

L'invention concerne de nouvelles formes galéniques à libération contrôlée contenant, comme principe actif, l'inhibiteur de PDE 5 vardénafil et/ou ses sels, hydrates, solvates pharmaceutiquement compatibles et/ou ses formes polymorphes. L'invention concerne également la production de ces formes galéniques, leur utilisation comme médicament ainsi que leur utilisation pour produire des médicaments servant à traiter et/ou à prévenir des maladies chez l'homme et l'animal.

Affiliated with

Also associated with

Rating

Formulations with controlled release of active ingredient does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulations with controlled release of active ingredient, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations with controlled release of active ingredient will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2022624